共查询到20条相似文献,搜索用时 31 毫秒
3.
Vitamin D is produced by exposure of 7-dehydrocholesterol in the skin to UV irradiation (UVR) and further converted in the skin to the biologically active metabolite, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2D 3) and other compounds. UVR also results in DNA damage producing cyclobutane pyrimidine dimers (CPD). We previously reported that 1,25(OH) 2D 3 at picomolar concentrations, protects human skin cells from UVR-induced apoptosis, and decreases CPD in surviving cells. 1,25(OH) 2D 3 has been shown to generate biological responses via two pathways—the classical steroid receptor/genomic pathway or a rapid, non-genomic pathway mediated by a putative membrane receptor. Whether the rapid response pathway is physiologically relevant is unclear. A cis-locked, rapid-acting agonist 1,25(OH) 2lumisterol 3 (JN), entirely mimicked the actions of 1,25(OH) 2D 3 to reduce fibroblast and keratinocyte loss and CPD damage after UVR. The effects of 1,25(OH) 2D 3 were abolished by a rapid-acting antagonist, but not by a genomic antagonist. Skh:hr1 mice exposed to three times the minimal erythemal dose of solar-simulated UVR and treated topically with 1,25(OH) 2D 3 or JN immediately after UVR showed reduction in UVR-induced UVR-induced sunburn cells ( p < 0.01 and <0.05, respectively), CPD ( p < 0.01 for both) and immunosuppression ( p < 0.001 for both) compared with vehicle-treated mice. These results show for the first time an in vivo biological response mediated by a rapid-acting analog of the vitamin D system. The data support the hypothesis that 1,25(OH) 2D 3 exerts its photoprotective effects via the rapid pathway and raise the possibility that other D compounds produced in skin may contribute to the photoprotective effects. 相似文献
6.
We employed genetically modified mice to examine the role of 1,25-dihydroxyvitamin D 3 [1,25(OH) 2D 3] on skeletal and calcium homeostasis. In mice expressing the null mutation for 25-hydroxyvitamin D 1 hydroxylase (1OHase −/−), or the vitamin D receptor (VDR −/−), 1,25(OH) 2D 3 and calcium were both required for optimal epiphyseal growth plate development, serum calcium and phosphorus alone were sufficient to mineralize skeletal tissue independent of 1,25(OH) 2D 3 and the VDR, and endogenous 1,25(OH) 2D 3 and the VDR were essential for baseline bone formation. In 2-week-old 1OHase −/− mice and in 2-week-old mice homozygous for the PTH null mutation(PTH −/−), PTH and 1,25(OH) 2D 3 were each found to exert independent and complementary effects on skeletal anabolism, with PTH predominantly affecting appositional trabecular bone growth and 1,25(OH) 2D 3 influencing both endochondral bone formation and appositional bone growth. Endogenous 1,25(OH) 2D 3 maintained serum calcium homeostasis predominantly by modifying intestinal and renal calcium transporters but not by producing net bone resorption. Administration of exogenous 1,25(OH) 2D 3 to double mutant PTH −/−1OHase −/− mice produced skeletal effects consistent with the actions of endogenous 1,25(OH) 2D 3. These studies reveal an important skeletal anabolic role for both endogenous and exogenous 1,25(OH) 2D 3 and point to a potential role for 1,25(OH) 2D 3 analogs in the treatment of disorders of bone loss. 相似文献
8.
We have studied two proteins potentially involved in the regulation of the 25-OH-D-1-hydroxylase, which is located in the renal mitochondria and which is responsible for the production of the steroid hormone 1,25(OH) 2D 3. The endogenous inhibitor of cyclic AMP-dependent protein kinase, PKI, is down regulated by 1,25(OH) 2D 3. Having cloned and sequenced PKI cDNA, we studied its message levels and found them to be regulated by 1,25(OH) 2D 3 tissue specifically in the kidney and in kidney cell culture. In other experiments we over expressed the ferredoxin component of the 1-hydroxylase and found it to be physically and chemically indistinguishable from those of classic steroidogenic tissues. The mRNA encoding the ferredoxin component is up-regulated by chronic vitamin D deficiency, which at the same time leads to sustained elevation in 1-hydroxylase activity; no short term effect of 1,25(OH) 2D 3 on ferredoxin mRNA in kidney cell culture could be demonstrated. Finally, there was an association between decreased phosphorylation of ferredoxin and decreased 1-hydroxylase activity brought about by treatment of cultured kidney cells with TPA. Control of the renal signaling events involved in the production of 1,25(OH) 2D 3 remains a fruitful area of investigation in the field of the metabolism and actions of vitamin D and its metabolites. 相似文献
9.
Of the various risk factors contributing to osteoporosis, dietary/lifestyle factors are important. In a clinical study we reported that women with caffeine intakes >300 mg/day had higher bone loss and women with vitamin D receptor (VDR) variant, tt were at a greater risk for this deleterious effect of caffeine. However, the mechanism of how caffeine effects bone metabolism is not clear. 1,25-Dihydroxy vitamin D 3 (1,25(OH) 2D 3) plays a critical role in regulating bone metabolism. The receptor for 1,25(OH) 2D 3, VDR has been demonstrated in osteoblast cells and it belongs to the superfamily of nuclear hormone receptors. To understand the molecular mechanism of the role of caffeine in relation to bone, we tested the effect of caffeine on VDR expression and 1,25(OH) 2D 3 mediated actions in bone. We therefore examined the effect of different doses of caffeine (0.2, 0.5, 1.0 and 10 mM) on 1,25(OH) 2D 3 induced VDR protein expression in human osteoblast cells. We also tested the effect of different doses of caffeine on 1,25(OH) 2D 3 induced alkaline phosphatase (ALP) activity, a widely used marker of osteoblastic activity. Caffeine dose dependently decreased the 1,25(OH) 2D 3 induced VDR expression and at concentrations of 1 and 10 mM, VDR expression was decreased by about 50–70%, respectively. In addition, the 1,25(OH) 2D 3 induced alkaline phosphatase activity was also reduced at similar doses thus affecting the osteoblastic function. The basal ALP activity was not affected with increasing doses of caffeine. Overall, our results suggest that caffeine affects 1,25(OH) 2D 3 stimulated VDR protein expression and 1,25(OH) 2D 3 mediated actions in human osteoblast cells. 相似文献
10.
1,25-Dihydroxyvitamin D 3, [1,25(OH) 2D 3], the biologically most active metabolite of vitamin D 3, is involved in the regulation of calcium homeostasis and bone metabolism. Recently, receptors for 1,25(OH) 2D 3 have also been shown in cells and tissues not directly related to calcium homeostasis. Experimental data obtained with leukemic and cancer cell lines, both in vitro and in vivo, showed the effects of 1,25(OH) 2D 3 on cell differentiation and proliferation. However, high doses of the sterol have to be used to observe these effects. Additional studies are needed to establish whether 1,25(OH) 2D 3 or suitable analogues have a therapeutic potential in malignant diseases without unacceptable toxicity like the development of hypercalcemia. 相似文献
12.
1,25-dihydroxyvitamin D 3 (1,25-(OH) 2D 3) is known to be involved in regulating the proliferation of parathyroid cells and PTH synthesis through reactions involving its nuclear receptor. We evaluated the effects of 1,25-(OH) 2D 3 and its hexafluorinated analog, 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D 3 (26,27-F 6-1,25-(OH) 2D 3), on parathyroid cells. The 1,25-(OH) 2D 3 and 26,27-F 6-1,25-(OH) 2D 3 each inhibited [ 3H]thymidine incorporation and ornithine decarboxylase (ODC) activity, which is important in cell proliferation, in primary cultured bovine parathyroid cells. The inhibitory effect of 26,27-F 6-1,25-(OH) 2D 3 on PTH secretion from parathyroid cells was significantly more potent than that of 1,25-(OH) 2D 3 between 10 −11 M and 10 −8 M. Study of 26,27-F 6-1,25-(OH) 2D 3 metabolism in parathyroid cells in vitro elucidated its slower degradation than that of 1,25-(OH) 2D 3. After 48 h of incubation with [1 β- 3H]26,27-F 6-1,25-(OH) 2D 3, two HPLC peaks, one for [1 β- 3H]26,27-F 6-1,25-(OH) 2D 3, and a second larger peak for [1 β- 3H]26,27-F 6-1,23(S),25-(OH) 3D 3, were detected. No metabolites were detected after the same period of incubation with 1,25-(OH) 2[26,27- 3H]D 3. We observed that 26,27-F 6-1,23(S),25-(OH) 3D 3 was as potent as 1,25-(OH) 2D 3 in inhibiting the proliferation of parathyroid cells. Data suggest that the greater biological activity of 26,27-F6-1,25-(OH)2D3 is explained by its slower metabolisms and by the retention of the biological potency of 26,27-F6-1,25-(OH)2D3 even after 23(S)-hydroxylation. 相似文献
14.
Since the discovery of the Vitamin D receptor (VDR) in mammary cells, the role of the Vitamin D signaling pathway in normal glandular function and in breast cancer has been extensively explored. In vitro studies have demonstrated that the VDR ligand, 1,25(OH) 2D 3, modulates key proteins involved in signaling proliferation, differentiation and survival of normal mammary epithelial cells. Anti-proliferative and pro-differentiating effects of 1,25(OH) 2D 3 have also been observed in VDR positive breast cancer cells, indicating that transformation per se does not abolish Vitamin D signaling. However, many breast cancer cell lines are less sensitive to 1,25(OH) 2D 3 than normal mammary epithelial cells. Reduced sensitivity to 1,25(OH) 2D 3 has been linked to alterations in Vitamin D metabolizing enzymes as well as down regulation of VDR expression or function. In this report, we describe results from a proteomics screening approach used to search for proteins involved in dictating sensitivity or resistance to Vitamin D mediated apoptosis in breast cancer cells. Several proteins not previously linked to 1,25(OH) 2D 3 signaling were identified with this approach, and a distinct subset of proteins was linked to 1,25(OH) 2D 3 resistance. Follow-up studies to determine the relevance of these proteins to Vitamin D signaling in general are in progress. 相似文献
15.
Prostate cancer is the most commonly diagnosed cancer in the majority of western countries. Due to their antiproliferative and proapoptotic activity, vitamin D analogues have been introduced recently as an experimental therapy for prostate cancer. Clusterin (CLU) is a glycoprotein that has two known isoforms generated in human cells. A nuclear form of CLU protein (nCLU) is pro-apoptotic, and a secretory form (sCLU) is pro-survival. In this study, we analyzed whether proapoptotic and antiproliferative effects of 1,25(OH) 2D 3 on LNCaP prostate cancer cells are modulated by expression of sCLU. Using colony forming assay, we studied the effect of treatment with different doses of 1,25(OH) 2D 3 (10 −6, 10 −7, 10 −10 M) on proliferation of LNCaP cells that were stable transfected and over-express sCLU (LNT-1) as compared to empty vector-transfected cells (LN/C). We also measured apoptosis using TUNEL assay. sCLU over-expression protected against both antiproliferative (30%) and proapoptotic (15%) effects of 1,25(OH) 2D 3, although this effect was statistically not significant. In conclusion, our findings demonstrate that expression of sCLU modulates growth regulatory effects of 1,25(OH) 2D 3 in prostate cancer indicating that CLU interferes with vitamin D signalling pathways. 相似文献
16.
1,25-Dihydroxyvitamin D 3, an endogenous ligand with the highest affinity for the vitamin D receptor (VDR), was labeled with 11C for use in biological experiments. The radionuclide was incorporated via the reaction of [ 11C]methyllithium on a methyl ketone precursor in tetrahydrofuran at −10 °C. Deprotection of the labeled intermediate yielded 2.5–3 GBq [26,27- 11C]1,25-dihydroxyvitamin D 3 [ 11C-1,25(OH) 2 D 3] with specific radioactivity averaging 100 GBq/μmol at the end of synthesis and HPLC purification. The entire process took 48 min from the end of radionuclide production. In vitro binding experiments in rachitic chick purified VDR demonstrated the high affinity binding of this novel tracer. Thus; 11C-1,25(OH) 2 D 3 is available for in vivo distribution studies and may be suitable for the positron emission tomography (PET) determination of VDR levels and occupancy in animals and humans. 相似文献
19.
Adequate supply of vitamin D 3 is not sufficient for the prevention of post-menopausal osteoporosis, because of a tightly regulated critical step in formation of the most active vitamin D metabolite 1,25-dihydroxyvitamin D 3. Direct application of 1,25(OH) 2D 3, however, was effective in reducing fracture rate and increasing bone mineral density as has been shown in large clinical studies. Extracts from Solanum glaucophyllum and Trisetum flavescens plants containing 1,25(OH)2D3-glycosides were characterized by their vitamin D-activity in a quail eggshell bioassay and applied in an osteoporosis model in ovariectomized rats. An extract from the grass T. flavescens and a purified extract from S. glaucophyllum were characterized by the absence of alkaloids and the analytically determined content of 1,25(OH)2D3. In the ovariectomized rat model after 6 months duration, the bone metabolism relevant markers serum calcium, 1,25(OH)2D3, urinary crosslinks and calcium were measured. At termination tibial mineral content was determined and as imaging procedure micro-computerized tomography was applied. The bisphosphonate alendronate was used as a positive standard. While alendronate reduced bone resorption, as seen in a reduced urinary crosslink excretion, both vitamin D metabolite-containing extracts were able to improve bone mineral density by an enhanced calcium turnover. 相似文献
|